Black Diamond Therapeutics (BDTX) EV to CFO (2020 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly EV to CFO came in at 0.53 in Q2 2026, up 177.96% on a YoY basis from 0.19 in Q2 2025, and up 243.15% quarter-over-quarter from 0.37 in Q1 2026.
Powered by 
Analysis
Black Diamond Therapeutics (BDTX) EV to CFO (2020 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has reported EV to CFO for 7 consecutive years, with 0.53 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EV to CFO rose 177.96% year-over-year to 0.53; the trailing twelve-month figure through Jun 2026 stood at 0.13 (up 231.62% YoY), and the FY2025 full-year result was 0.34, up 194.7% from the prior year.
- EV to CFO rose to 0.53 in Q2 2026 per BDTX's latest filing, from 0.37 in the prior quarter.
- Across five years, EV to CFO topped out at 5.02 in Q3 2022 and bottomed at 11.76 in Q3 2024.
- Historically, EV to CFO has averaged 1.9 across 5 years, with a median of 0.68 in 2023.
- The sharpest annual moves came in 2022 and 2024: EV to CFO soared 285.99% in 2022, then tumbled 5386.08% in 2024.
- Over 5 years, EV to CFO stood at 2.61 in 2022, then slumped by 137.7% to 0.98 in 2023, then slumped by 52.95% to 1.5 in 2024, then climbed by 0.15% to 1.5 in 2025, then soared by 135.35% to 0.53 in 2026.
- According to Business Quant data, EV to CFO over the past three periods registered 0.53, 0.37, and 1.5 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Black Diamond Therapeutics | 111.58 Mn | 1.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.53 |
| Mar 31, 2026 | -0.37 |
| Dec 31, 2025 | -1.50 |
| Sep 30, 2025 | -10.23 |
| Jun 30, 2025 | 0.19 |
| Mar 31, 2025 | -1.21 |
| Dec 31, 2024 | -1.50 |
| Sep 30, 2024 | -11.76 |
| Jun 30, 2024 | -9.50 |
| Mar 31, 2024 | -7.13 |
| Dec 31, 2023 | -0.98 |
| Sep 30, 2023 | -0.21 |
| Jun 30, 2023 | -6.61 |
| Mar 31, 2023 | 1.72 |
| Dec 31, 2022 | 2.61 |
| Sep 30, 2022 | 5.02 |
| Jun 30, 2022 | 3.96 |
| Mar 31, 2022 | 2.77 |
| Dec 31, 2021 | 0.69 |
| Sep 30, 2021 | -2.70 |